Name | 5-(3-chlorophenyl)-N-[4-(morpholin-4-ylmethyl)phenyl]furan-2-carboxamide |
---|---|
Synonyms |
QCR-12
5-(3-Chlorophenyl)-N-[4-(4-morpholinylmethyl)phenyl]-2-furamide HMS2426M13 2-Furancarboxamide, 5-(3-chlorophenyl)-N-[4-(4-morpholinylmethyl)phenyl]- cc-693 CID-2011756 CID 2011756 |
Description | CID 2011756 is an ATP competitive PKD inhibitor, with an IC50 of 3.2 µM for PKD1 in cell free assay, and also shows cellular pan-PKD inhibitory activity against PKD2 and PKD3 (IC50, 0.6 and 0.7 µM, respectively). CID 2011756 also has antitumor activity. |
---|---|
Related Catalog | |
Target |
Cellular PKD2:0.6 μM (IC50) Cellular PKD3:0.7 μM (IC50) PKD1:3.2 μM (IC50) |
In Vitro | CID 2011756 is an ATP-competitive PKD1 inhibitor, with an IC50 of 3.2 µM. CID 2011756 decreases the phosphorylation of endogenous PKD1 Ser916 in LNCaP cancer cells with an EC50 of 10±0.7 µM. CID 2011756 also has cellular pan-PKD inhibitory effects, with IC50s of 0.6±0.1 µM and 0.7±0.2 µM for PKD2 and PKD3, respectively[1]. |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 491.0±45.0 °C at 760 mmHg |
Molecular Formula | C22H21ClN2O3 |
Molecular Weight | 396.867 |
Flash Point | 250.8±28.7 °C |
Exact Mass | 396.124084 |
PSA | 58.20000 |
LogP | 3.69 |
Appearance | white solid |
Vapour Pressure | 0.0±1.2 mmHg at 25°C |
Index of Refraction | 1.633 |
Storage condition | -20℃ |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H302-H319 |
Precautionary Statements | P305 + P351 + P338 |
RIDADR | NONH for all modes of transport |